DAIC

JULY 10, 2024

Findings from an observational analysis of ARISE-HF trial participants, newly-published in the Journal of the American College of Cardiology, JACC, shed light on the racial and ethnic disparities in diabetic cardiomyopathy (DbCM), which researchers note may have the potential to inform clinical practice, interventions, and policies.

Cardiomyopathy 113

Cardiomyopathy Diabetes Health Disparities Exercise 113

Cardiovascular Diabetology

JANUARY 27, 2024

Underweight imposes significant burden on cardiovascular outcomes in patients with diabetes mellitus. However, less is known about the impact of serial change in body weight status measured as body mass index.

Cardiac Arrest 116

Cardiac Arrest Diabetes Outcomes Research 116

Cardiovascular Diabetology

JULY 17, 2024

The beneficial effects of fenofibrate on atherosclerotic cardiovascular disease (ASCVD) outcomes in patients with diabetes and statin treatment are unclear. We investigated the effects of fenofibrate on all-ca.

Diabetes 105

Diabetes Cardiovascular Disease Outcomes Research 105

The New England Journal of Medicine

MARCH 28, 2025

Among participants with type 2 diabetes and cardiovascular disease, chronic kidney disease, or both, oral semaglutide (14 mg) was associated with a lower risk of cardiovascular events than placebo after 4 years of follow-up.

Diabetes 75

Diabetes Kidney Disease Cardiovascular Disease Outcomes 75

HCPLive

MARCH 5, 2024

Initiation of SGLT2 inhibitors reduced the risk of composite anemia outcomes, compared with GLP-1 RA, among patients with type 2 diabetes and CKD.

Diabetes 105

Diabetes Outcomes 105

HCPLive

DECEMBER 19, 2023

While the ACT program did not benefit patients in the study’s primary outcome measure, it did lead to some other benefits for those with type 1 diabetes.

Diabetes 105

Diabetes Outcomes 105

Med Page Today

DECEMBER 12, 2023

(MedPage Today) -- Adding metformin to insulin treatment for pregnant women with preexisting type 2 or gestational diabetes did not reduce composite neonatal adverse outcomes, according to the randomized MOMPOD trial. The composite outcome -.

Diabetes 97

Diabetes Outcomes 97

HCPLive

FEBRUARY 20, 2024

Viral Shah, MD, joins Diabetes Dialogue to discuss a recent study examining associations between time in range and other advanced CGM metrics with diabetic retinopathy and the implications for use in predicting other microvascular outcomes.

Diabetes 64

Diabetes Outcomes 64

Cardiometabolic Health Congress

JUNE 14, 2024

Recent over-the-counter (OTC) approvals for CGM systems are transforming diabetes management and lifestyle management for those without diabetes, making this an exciting time for healthcare professionals and their patients. These enhancements offer benefits beyond diabetes management, including support for women across the lifespan.

Technology 105

Technology Diabetes Outcomes Innovation 105

The New England Journal of Medicine

MARCH 26, 2025

In this trial, patients with type 2 diabetes had a lower incidence of major cardiovascular outcomes with a systolic blood-pressure target of less than 120 mm Hg than with a target of less than 140 mm Hg.

Blood Pressure 75

Blood Pressure Diabetes Outcomes 75

Cardiovascular Diabetology

FEBRUARY 27, 2024

Non-alcoholic fatty liver disease (NAFLD), identified by the Fatty Liver Index (FLI), is associated with increased mortality and cardiovascular (CV) outcomes. Whether this also applies to type 1 diabetes (T1D).

Diabetes 110

Diabetes Risk Factors Outcomes Research 110

Cardiovascular Diabetology

AUGUST 6, 2024

Objective To explore trends in prognosis and use of glucose-lowering drugs (GLD) in patients with diabetes and coronary artery disease (CAD). Research design and methods All patients with diabetes and CAD undergoing a coronary angiography between 2010 and 2021 according to the Swedish Angiography and Angioplasty Registry were included.

Coronary Artery Disease 98

Coronary Artery Disease Diabetes Myocardial Infarction Heart Failure 98

CardiacWire

MARCH 12, 2025

One of the biggest risk factors for patients who need coronary revascularization is diabetes, and a new study in JAMA suggests CABG could be a better option than FFR-guided PCI when it comes to long term outcomes for these patients. Patients with T2D who underwent PCI had a 44% higher MACCE risk than those who underwent CABG.

Diabetes 59

Diabetes Stent Stents Risk Factors 59

Med Page Today

NOVEMBER 16, 2024

(MedPage Today) -- CHICAGO -- The cardiovascular outcome benefit of a tighter systolic blood pressure target was affirmed in patients with type 2 diabetes in the randomized BPROAD trial from China. A target of less than 120 mm Hg reduced a composite.

Blood Pressure 81

Blood Pressure Diabetes Outcomes 81

Journal of the American Heart Association

DECEMBER 24, 2024

The primary outcome was atherothrombotic major adverse cardiovascular events as a composite outcome of cardiovascular mortality, nonfatal stroke, and nonfatal myocardial infarction. Patients were propensity matched in a 1:1 ratio using a caliper distance of 0.2 without replacement.

Diabetes 75

Diabetes Myocardial Infarction Outcomes Stroke 75

American College of Cardiology

APRIL 26, 2024

Since limb events are major drivers of morbidity in diabetic patients with peripheral (PAD) and coronary artery disease (CAD), does the addition of ticagrelor to background therapy of aspirin improve limb events?

Diabetes 68

Diabetes Coronary Artery Disease Outcomes Article 68

HCPLive

DECEMBER 19, 2023

Addressing a lack of quantitative data on AID, this study used validated measures in a real-world setting to corroborate the psychosocial benefits seen in prior qualitative research.

Diabetes 105

Diabetes Outcomes Research 105

HCPLive

MARCH 26, 2024

A study in China identified a negative and non-linear relationship between hemoglobin levels and a renal composite end point in patients with DKD.

Kidney Disease 98

Kidney Disease Diabetes Outcomes 98

HCPLive

JULY 24, 2024

A database analysis linked semaglutide use to notable reductions in the rates of diabetic macular edema and vitreous hemorrhage in diabetic retinopathy.

Diabetes 59

Diabetes Hemorrhage Outcomes 59

HCPLive

OCTOBER 4, 2024

An EADV 2024 study suggests dupilumab use during pregnancy is generally safe and may lower risks of preterm labor, gestational hypertension, and diabetes.

Diabetes 110

Diabetes Outcomes Hypertension 110

HCPLive

MARCH 31, 2025

Justin Mark, MD, discusses an analysis of the FIGHT trial looking at racial and ethnic differences in heart failure outcomes.

Heart Failure 69

Heart Failure Outcomes Diabetes 69

Cardiometabolic Health Congress

JANUARY 8, 2025

Last month, the 2025 American Diabetes Association (ADA) guidelines were introduced, providing updates for diagnosing and managing diabetes and prediabetes. This ensures patients have contingency plans to maintain effective diabetes management during periods of unavailability.

Diabetes 59

Diabetes Outpatient Inpatient Outcomes 59

Cardiometabolic Health Congress

JANUARY 30, 2024

As an expert on metabolic control and type 2 diabetes (T2D), Dr. Hallberg once gave a TedTalk titled Reversing Type 2 diabetes starts with ignoring the guidelines , which quickly accumulated 8.6 Research now suggests the potential for diabetes reversal through other means that have only recently been embraced in official guidelines.

Webinar 105

Webinar Diabetes Education Diet 105

NEJM Journal Watch - Cardiology

APRIL 30, 2024

The highly selective aldose reductase inhibitor AT-001 did not improve exercise capacity in a randomized trial.

Cardiomyopathy 81

Cardiomyopathy Diabetes Exercise Outcomes 81

Medical Xpress - Cardiology

OCTOBER 25, 2024

Sodium-glucose co-transporter 2 (SGLT2) inhibitors reduce the risk of cardiovascular and kidney outcomes in patients with type 2 diabetes, but it is unclear whether their effects differ based on patients' age.

Outcomes 74

Outcomes Diabetes 74

Dr. Paddy Barrett

JANUARY 2, 2025

The Defining Risk module includes lessons on: Defining Metabolic Health Cholesterol Principles Understanding Your Cholesterol Panel Advanced Cholesterol Testing Lipoprotein (a) - Lp(a) Insulin Resistance Metabolic Syndrome Pre-Diabetes & Diabetes Assessing Visceral Fat How To Measure Fitness The Importance of Muscle Metrics.

Cholesterol 88

Cholesterol Heart Disease Blood Pressure Coronary Angiogram 88

HCPLive

DECEMBER 12, 2023

Results from the MOMPOD RCT indicate metformin added to insulin did not reduce the frequency of a composite adverse neonatal outcome in pregnant adults with diabetes.

Diabetes 52

Diabetes Outcomes 52

Cardiovascular Diabetology

JUNE 6, 2024

Sodium glucose cotransporter 2 (SGLT2) inhibitors significantly improve cardiovascular outcomes in diabetic patients; however, the mechanism is unclear. We hypothesized that dapagliflozin improves cardiac outc.

Diabetes 64

Diabetes Heart Failure Outcomes Research 64

Cardiovascular Diabetology

MARCH 25, 2025

Understanding the relationship between serum ferritin levels and cardiovascular outcomes in type 2 diabetes is crucial for improving risk stratification and guiding therapeutic interventions aimed at preventin.

BMI 59

BMI Diabetes Cardiovascular Disease Outcomes 59

CardiacWire

JANUARY 22, 2025

Starting with the good news, GLP-1s lowered risks for 42 health outcomes while increasing risks for 19 outcomes. Its also worth noting that the data came from military veterans who were older and mainly white, so the outcomes might not apply to other populations. year follow-up.

Obesity 59

Obesity Cardiac Arrest Dementia Outcomes 59

Cardiovascular Diabetology

JULY 3, 2024

Despite improved glycemic treatment, the impact of glycation on pathological consequences may persist and contribute to adverse clinical outcomes in diabetes. In the present study we.

Diabetes 64

Diabetes Kidney Disease Outcomes Research 64

American College of Cardiology

FEBRUARY 21, 2024

What are the cardiovascular (CV) outcomes by treatment group in participants randomly assigned to insulin glargine, glimepiride, liraglutide, or sitagliptin, added to baseline metformin, in GRADE (Glycemia Reduction Approaches in Type 2 Diabetes: A Comparative Effectiveness Study)?

Diabetes 46

Diabetes Outcomes Article 46

DAIC

MARCH 14, 2025

Simultaneous pancreas-kidney (SPK) transplants are known to improve the quality of life and long-term survival of patients with insulin dependent diabetes and advanced renal disease. I have witnessed firsthand the significant benefits for patients with diabetes and kidney failure of receiving a pancreas and kidney transplant.

Heart Transplant 87

Heart Transplant Transplant Pediatrics Quality of Life 87

Cardiovascular Diabetology

JULY 15, 2024

BMI variability has been associated with increased cardiovascular disease risk in individuals with type 2 diabetes, however comparison between clinical studies and real-world observational evidence has been la.

BMI 59

BMI Diabetes Cardiovascular Disease Outcomes 59

HCPLive

SEPTEMBER 25, 2024

There were no differences in the treatment effect of ertugliflozin on gout-related outcomes in subgroups based on eric acid quintile or other baseline characteristics.

Outcomes 59

Outcomes Diabetes 59

Circulation

DECEMBER 14, 2023

Despite the known higher risk of cardiovascular disease in individuals with type 2 diabetes, the pathophysiology and optimal management of diabetic foot ulcers (DFUs), a leading complication associated with diabetes, is complex and continues to evolve.

Diabetes 76

Diabetes Peripheral Arterial Disease Health Disparities Cardiovascular Disease 76

American College of Cardiology

MARCH 15, 2024

What are the outcomes in patients with left main disease with and without diabetes undergoing percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG)?

Coronary Artery Bypass Graft 59

Coronary Artery Bypass Graft Diabetes Outcomes Article 59